Women treated for some breast cancers remain at risk for 20 years, according to latest study
The findings raise questions about the current practice of treating women with tamoxifen or aromatase inhibitors for five years after the tumour is removed
Published: 9:01am, 9 Nov, 2017
Updated: 2:55pm, 20 Jul, 2018
Copyright © 2019 South China Morning Post Publishers Ltd. All rights reserved.